Weight deficit at birth and Turner's syndrome

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 5, 2007, Pages 607-613

  Wisniewski, Andrzej ^a   Milde, Katarzyna ^a   Stupnicki, Romuald ^a   Szufladowicz Wozniak, Jolanta ^b  

^a JÓZEF PI SUDSKI UNIVERSITY OF PHYSICAL EDUCATION IN WARSAW   (Poland)

^b Holy Family Clinic of Gynecology and Obstetrics in Warsaw   (Poland)

Author keywords

Birth weight; Small for gestational age; Turner's syndrome

Indexed keywords

ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; KARYOTYPING; MAJOR CLINICAL STUDY; NEWBORN; POLAND; PUBLIC HOSPITAL; SMALL FOR DATE INFANT; TURNER SYNDROME; UNIVERSITY HOSPITAL; X CHROMOSOME;

EID: 34250695536     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.5.607     Document Type: Article

References (46)

1. Davenport ML, Calikoglu AS. Turner syndrome. In: Pescovitz OH, Eugster EA, eds. Pediatric Endocrinology, Mechanisms, Manifestations, and Management. Lippincott, Williams & Wilkins, 2004; 201-231.
2. Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 1991; 87: 81-83.
3. Chu CE, Donaldson MDC, Kelnar CJH, Smail PJ, Greene SA, Connor JM. Turner's syndrome in Scotland; prevalence, diagnosis and follow-up. Horm Res 1995; 44: 89.
4. Gravholt CH, Juul S, Naeraa RW, Hansen J. Prenatal and postnatal prevalence of Turner's syndrome: a registry study. BMJ 1996; 312: 16-21.
5. Ranke MB. Turner and Noonan syndrome: disease-specific growth and growth-promoting therapies. In: Kelnar CJH, Savage MO, Stirling HF, Saenger P, eds. Growth Disorders. London: Chapman & Hall Medical, 1998; 623-639.
6. Ranke MB, Stubbe P, Majewski F, Bierich JR. Spontaneous growth in Turner's syndrome. Acta Paediatr Scand 1988; 343: 22-30.
7. Naeraa RW, Nielsen J. Standards for growth and final height in Turner's syndrome. Acta Paediatr Scand 1990; 79: 182-190.
8. Karlberg J, Albertsson-Wikland K, Nilsson KO, Ritzen EM, Westphal O. Growth in infancy and childhood in girls with Turner's syndrome. Acta Paediatr Scand 1991; 80: 1158-1165.
9. Davenport ML, Punyasavatsut N, Stewart PW, Gunther DF, Savendahl L, Sybert VP. Growth failure in early life, an important manifestation of Turner syndrome. Horm Res 2002; 57: 157-164.
10. Wisniewski A, Rudzka-Kocjan A, Lecka A, Milde K. Turner's syndrome: postnatal growth failure in the first months of life. Horm Res 2003; 60: 35 (Abst).
11. Wisniewski A, Gornicki J, Milde K. Turner's syndrome: postnatal catch-down growth in the first months of life, or difficulty in measuring newborns? Horm Res 2004; 62: 160 (Abst).
12. Gibson AT, Carney S, Wright NP, Wales JKH. Measurement and the newborn infant. Horm Res 2003; 59: 119-128.
13. Usher R, McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurement in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 1969; 74: 901-910.
14. Ekholm K, Carstensen J, Finnstrom O, Sydsjo G. The probability of giving birth among women who were born preterm or with impaired fetal growth: a Swedish population-based registry study. Am J Epidemiol 2005; 161: 725-733.
15. Dejin-Karlsson E, Ostergren PD. Country of origin, social support and the risk of small for gestational age birth. Scand J Public Health 2004; 32: 442-444.
16. Karlberg J, Albertsson-Wikland K. Growth in full-term small-for-gestational age infants: from birth to final height. Pediatr Res 1995; 38: 733-739.
17. Lipsky S, Easterling TR, Holt VL. Detecting small for gestational age infants: the development of a population based reference for Washington state. Am J Perinatol 2005; 22: 405-412.
18. Karlberg J, Albertsson-Wikland K, Naeraa RW, Rongen-Westerlaken C, Wit J-M. Reference values for spontaneous growth in Turner girls and its use in estimating treatment effects. In: Hibi I, Takano K, eds. Basic and Clinical Approach to Turner Syndrome. Amsterdam: Excerpta Medica, Elsevier Science Publishers BV, 1993; 83-92.
19. Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner's syndrome. Arch Dis Child 1985; 60: 932-935.
20. Lippe B, Frane J. Growth in Turner syndrome. In: Ranke MB, Rosenfeld RG, eds. Turner Syndrome: Growth Promoting Therapies. Amsterdam: Excerpta Medica, Elsevier Science Publishers BV, 1991; 59-65.
21. Bernasconi S, Giovannelli G, Volta C, et al. Spontaneous growth in Turner syndrome: preliminary results of an Italian multicenter study. In: Ranke MB, Rosenfeld RG, eds. Turner Syndrome: Growth Promoting Therapies. Amsterdam: Excerpta Medica, Elsevier Science Publishers BV, 1991; 53-57.
22. Cabrol S, Saab C, Gourmelen M, Raux-Demay MC, Le Bouc Y. Syndrome de Turner: croissance staturoponderale et maturation osseuse spontanees. Arch Pediatr 1996; 3: 313-318.
23. Massa G, Malvaux P, Vanderschueren-Lodeweyckx M. Spontaneous growth in Turner syndrome: the Belgian experience. In: Ranke MB, Rosenfeld RG, eds. Turner Syndrome: Growth Promoting Therapies. Amsterdam: Excerpta Medica, Elsevier Science Publishers BV, 1991; 95-99.
24. Rochiccioli P, Pienkowski C, Tauber MT. Spontaneous growth in Turner syndrome: a study of 61 cases. In: Ranke MB, Rosenfeld RG, eds. Turner Syndrome: Growth Promoting Therapies. Amsterdam: Excerpta Medica, Elsevier Science Publishers BV, 1991; 107-112.
25. Ranke MB, Chavez-Meyer H, Blank B, Frisch H, Häusler G. Spontaneous growth and bone age development in Turner syndrome: results of a multicentric study 1990. In: Ranke MB, Rosenfeld RG, eds. Turner Syndrome: Growth Promoting Therapies. Amsterdam: Excerpta Medica, Elsevier Science Publishers BV, 1991; 101-106.
26. Wisniewski A, Stupnicki R, Romer TE. Spontaneous growth in Turner's syndrome: reference values for body height. J Pediatr Endocrinol Metab 2002; 15: 1413-1414 (Abst).
27. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity: British children 1965. Arch Dis Child 1966; 41: 454-471, 613-635.
28. Prader A, Largo RH, Molinari L, Issler C. Physical growth of Swiss children from birth to 20 years of age: First Zürich Longitudinal Study of Growth Development. Helv Paediatr Acta 1988; 52: 1-125.
29. Salgin B, Amin R, Yuen K, Williams RM, Murgatroyd P, Dunger DB. Insulin resistance is an intrinsic defect independent of fat mass in women with Turner's syndrome. Horm Res 2006; 65: 69-75.
30. Ogata T, Muroya K, Matsuo N, Shinohara O, Yorifuji T, Nishi Y, Hasegawa Y, Horikawa R, Tachibana K. Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients. J Clin Endocrinol Metab 2001; 86: 5498-5508.
31. Rao E, Weiss B, Fukami M, Mertz A, Meder J, Ogata T, Heinrich U, Garcia-Heras J, Schiebel K, Rappold GA. FISH-deletion mapping defines a 270-kb short stature critical interval in the pseudoautosomal region PAR1 on human sex chromosomes. Hum Genet 1997; 100: 236-239.
32. Clement-Jones M, Schiller S, Rao E, Blaschke RJ, Zuniga A, Zeller R, Robson SC, Binder G, Glass I, Strachan T, Lindsay S, Rappold GA. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 2000; 9: 695-702.
33. Zinn AR, Ross JL. Critical regions for Turner syndrome phenotypes on the X chromosome. In: Saenger P, Pasquino AM, eds. Optimizing Health Care for Turner Patients in 21st Century. Amsterdam: Elsevier, 2000; 23-27.
34. Therman E, Susman B. The similarity of phenotypic effects caused by Xp and Xq deletions in the human female, a hypothesis. Hum Genet 1990; 85: 175-183.
35. Prueih RL, Ross JL, Zinn AR. Physical mapping of nine Xq translocation breakpoints and identification of XPNPEP2 as a premature ovarian failure candidate gene. Cytogenet Cell Genet 2000; 89: 44-50.
36. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, Gluckman PD. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997; 82: 402-406.
37. Godfrey KM, Hales CN, Osmond C, Barker DJP, Taylor KP. Relation of cord plasma concentration of proinsulin, 32-33 split proinsulin, insulin and C-peptide to placental weight and the baby's size and proportions at birth. Early Hum Dev 1996; 46: 129-140.
38. Gluckman PD. The endocrine regulation of fetal growth in late gestation: the role of insulin-like growth factor. J Clin Endocrinol Metab 1995; 80: 1047-1050.
39. Cattanach BM, Peters J, Ball S, Rasberry C. Two imprinted gene mutations: three phenotypes. Hum Mol Genet 2006; 9: 2263-2273.
40. Cattanach BM, Beechey CV, Peters J. Interactions between imprinting effects in the mouse. Genetics 2004; 168: 397-413.
41. Chernausek SD. Mendelian genetic causes of the short child born small for gestational age. J Endocrinol Invest 2006; 29 (Suppl): 16-20.
42. Fowden AL, Sibley C, Reik W, Constancia M. Imprinted genes, placental development and fetal growth. Horm Res 2006; 65 (Suppl): 50-58.
43. Skinner JA, Cattanach BM, Peters J. The imprinted oedematous-small mutation on mouse chromosome 2 identifies new roles for Gnas and Gnasxl in development. Genomics 2002; 80: 373-375.
44. Skuse DH, James RS, Bishop DV, Coppin B, Dalton P, Aamodt Leeper G, Bacarese-Hamilton M, Creswell C, McGurk R, Jacobs PA. Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 1997; 387: 705-708.
45. Sagi L, Gawlik A, Małecka-Tendera E, et al. Clinical significance of parental origin of the X chromosome in Turner syndrome. Horm Res 2004; 62: 160 (Abst).
46. Hamelin C, Anglin G, Quigley CA, Deal C. Genomic imprinting effect on GH response and on risk of sensorineural hearing loss in Turner syndrome. Horm Res 2004; 62: 160 (Abst).